CHARLES MCSWAIN, D.O.
2225 E FLAMINGO RD SUITE 105, LAS VEGAS, NV 89119
NPI Number
1235100801
Practice location · View on Google Maps
Total Medicaid Payments
$206,601
-34% vs specialty average
Patients Seen
3,172
Total Claims
4,692
$ Per Patient
$65
Specialty avg: $54
Specialty Rank
#77 of 420
Family Medicine providers in Nevada
Peer Average
$314,431
Average total for Family Medicine
Claims per Patient
1.5
Average visits / services per person
Payments by Year
How much Medicaid paid this provider each year. Large jumps can indicate changes in practice volume or billing patterns.
| Year | Total Paid | % of Max |
|---|---|---|
| 2018 | $130,478 | |
| 2019 | $19,111 | |
| 2020 | $7,053 | |
| 2021 | $19,525 | |
| 2022 | $22,382 | |
| 2023 | $8,052 |
Procedure Code Breakdown
The specific medical services this provider billed Medicaid for. Each HCPCS/CPT code represents a different type of visit, test, or treatment.
| HCPCS Code | Description | Claims | Paid | % of Total | Avg per Claim |
|---|---|---|---|---|---|
| 99309 | Nursing facility visit — moderate problem | 1,459 | $97,526 | 47.2% | $67 |
| H0020 | Alcohol or drug methadone administration and services | 2,300 | $91,506 | 44.3% | $40 |
| 99214 | Office visit for a moderate problem (established patient) | 99 | $6,566 | 3.2% | $66 |
| 80305 | Drug or substance testing | 387 | $5,471 | 2.6% | $14 |
| 99306 | Nursing facility admission — complex first day care | 28 | $3,638 | 1.8% | $130 |
| 99401 | Medical service or procedure | 54 | $1,894 | 0.9% | $35 |
| 1123F | Medical service or procedure | 181 | $0 | 0.0% | $0 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 184 | $0 | 0.0% | $0 |
About This Data
This data comes from the HHS Medicaid Provider Spending dataset (opendata.hhs.gov). It shows payments made through Nevada Medicaid from 2018–2024. High payments do not mean a provider is doing anything wrong — some specialties naturally cost more, and busy providers see more patients. But unusually high numbers compared to peers can be worth a closer look.